• Home   ›
  •   Global Tenders   › Tender Reference No: 96727818

    • Bids Are Invited For Acquisition Of The Drug Lanadelumab 150 Mg/Ml Injectable Solution.

    Tender Detail

    96727818
    You can view only after subscription.
    117/25/2025
    Self-Funded
    Bids Are Invited For Acquisition Of The Drug Lanadelumab 150 Mg/Ml Injectable Solution.
    NCB
    You can view only after subscription.
    South America
    BRIC,G20
    29-05-2025

    Work Detail

    Pharmacological Group: Monoclonal Antibody, Active Principle: Lanadelumab, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 150, Unit: Mg / Ml, Volume: 2 Ml, Presentation: Flask, Accessory: Infusion Set, Form Supply: Unit

    Key Value

    Tender Value
    Refer document

    Attachment

    FileName File Description
    Global Tender Document Tender Notice
    Attachments
    Click Here To Download
    Tender Documents

    Additional Details Available on Click
    ✓ Tendering Authority
    ✓ Publication Document
    (Tender Document / Tender Notice )
    Disclaimer :
    We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
    Tell us about your Product / Services,
    We will Find Tenders for you
    Cnet Technologies

    We are a group of professionals specializing in custom software development, web development, mobile app development, IOT base solutions, web design, graphics & Enterprise solutions provid.

    About Us

    Services

    Browse Tenders

    For Sales Inquiry

    Connect With Us

    Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

    For Tender Information Services Visit : TenderDetail